Merck (MRK) Payables (2016 - 2025)
Historic Payables for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $6.2 billion.
- Merck's Payables rose 1115.3% to $6.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 billion, marking a year-over-year increase of 1115.3%. This contributed to the annual value of $6.2 billion for FY2024, which is 433.38% up from last year.
- According to the latest figures from Q3 2025, Merck's Payables is $6.2 billion, which was up 1115.3% from $5.9 billion recorded in Q2 2025.
- In the past 5 years, Merck's Payables registered a high of $6.4 billion during Q4 2021, and its lowest value of $5.0 billion during Q3 2021.
- Over the past 5 years, Merck's median Payables value was $5.6 billion (recorded in 2024), while the average stood at $5.7 billion.
- In the last 5 years, Merck's Payables tumbled by 555.86% in 2022 and then surged by 1115.3% in 2025.
- Merck's Payables (Quarter) stood at $6.4 billion in 2021, then fell by 3.59% to $6.1 billion in 2022, then decreased by 3.92% to $5.9 billion in 2023, then increased by 4.33% to $6.2 billion in 2024, then rose by 0.42% to $6.2 billion in 2025.
- Its Payables was $6.2 billion in Q3 2025, compared to $5.9 billion in Q2 2025 and $5.9 billion in Q1 2025.